Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-beta-catenin axis

CONCLUSION: The combination of evodiamine and cisplatin may be a novel strategy for combating cisplatin resistance in NSCLC.PMID:38630183 | DOI:10.1007/s11033-024-09477-7

Source: Mol Biol Cell - April 17, 2024 Category: Molecular Biology Authors: Munmun Panda Stuti Biswal Bijesh K Biswal Source Type: research